Staxyn is a very effective prescription medicine used to treat erectile dysfunction in men. The drug contains Vardenafil as its active component. This drug is being manufactured by Bayer Pharmaceuticals. The orally disintegrating form of the medication was initially approved by the FDA in 2003. Vardenafil is one of the first line drugs used for the treatment of impotence in men and it has gained popularity in Canada as well as the United States.
The active ingredient of Staxyn 10 is Vardenafil which belongs to the family of phosphodiesterase 5 (PDE5) inhibitors. The drug works by bringing about the release of nitric oxide (NO) from the blood vessels of corpus callosum. NO is a vasodilator and is responsible for relaxing the smooth muscle walls of the penile blood vessels so that more blood can be directed towards the penis for a sustained erection1.
Staxyn comes as a packet of 4 white colored, orally disintegrating tablets that dissolve readily when placed on the tongue. The recommended dosage is 10 mg, taken 60 minutes before sexual activity, and is not to be taken more than once daily. Although you take the medication 60 minutes prior to sex, an erection will not be achieved until you receive sexual arousal (stimuli).
The primary indication for the prescription of this drug is erectile dysfunction, for which it has been proven to be extremely effective.
Approximately 2-15% of the patients using Staxyn have reported the following side effects
Upper respiratory tract infections like nasopharyngitis
The following precautions should be practiced with the use of Staxyn.
Patients undergoing hemodialysis
Patients with moderate or severe hepatic impairment
Patients taking nitrates or nitric oxide donors like GTN tablets as both have blood pressure lowering effect2
It is recommended that the drug be used without any fluids. It can, however, be taken with or without food.
Patients in whom sexual activity is inadvisable, for example, those with cardiovascular risk3, should avoid taking Staxyn.
Is the erection lasts for more than 4 hours, a condition known as Priapism, seek immediate medical care.
In the event of sudden visual loss in one or both the eyes, the use of this drug should be stopped at once and immediate medical help should be sought.
People experiencing decreased hearing or sudden hearing loss should discontinue using this drug and should consult a doctor at once.
This medication can augment the effects of antihypertensive drugs so patients using antihypertensive medications should use both the drugs with caution. If possible, concomitant use should be avoided and the drugs should be used according to doctor’s advice.
People with blood disorders like sickle cell anemia or leukemia should inform their doctor if they are to take Staxyn 10mg tablets.
This drug provides no protection against the sexually transmitted infections (STIs). Therefore, adequate protective measures should be adopted to avoid contracting STIs.
The drug is not approved for use in women.
Always take Staxyn upon a doctor’s prescription and always discuss any pre-existing disease at length with your doctor or healthcare provider before taking it.
Potent CYP3A4 inhibitors: ie. ritonavir, indinavir, ketoconazole etc.
Moderate CYP3A4 inhibitors: ie. erythromycin
Alpha blockers: ie. doxazosin
Nitrates: ie isosorbide, sublingual/spray nitroglycerin
Class IA or III antiarrhythmic drugs: ie. amiodarone, procainamide, quinidine, sotalol
This list is not all inclusive and you should ask your pharmacist or doctor if Staxyn interacts with any medication you are taking
An effective and safe drug approved by the FDA for the treatment of erectile dysfunction in men. The drug contains Vardenafil, a phosphodiesterase 5 inhibitor, and has been proved to be quite efficient in onset and maintenance of erection.
The drug included in Staxyn10mg is Vardenafil which brings about erection by causing the penile blood vessels to dilate. This increases the blood flow in the penis and helps bring about an erection.
Store Staxyn 10mg at room temperature i.e. 25oC. The permitted range of temperature for the storage is 15-30oC. Store the medicine in the packet it originally comes in, away from light and heat in a dry, cool place. Always keep the drug out of reach of children.
Staxyn 10 mg is available as orally disintegrating tablets online at You Drugstore. It comes as a pack of 4 orally perishable tablets.
There is NO alternative to Staxyn 10 mg. It should not be used interchangeably with Vardenafil 10 mg, film-coated tablets (Levitra) owing to the fact that Staxyn10mg lasts longer in the systemic blood circulation system. Patients who require higher or lower doses should be prescribed the film coated form of Vardenafil instead of Staxyn.
The drug should be taken orally, without any fluids. The tablet disintegrates immediately when placed on the tongue. One may or may not eat any solid meals while taking Staxyn. The usual prescribed dosage of the drug is one 10mg tablet per day. However, always use the drug as prescribed by your doctor. Ideally, the drug should be taken an hour before engaging in sexual activity.
The most common disease for which Staxyn is prescribed is erectile dysfunction.
Erectile dysfunction (or impotence) means inability to have or maintain an erection long enough to have sexual intercourse. The condition is common in men over the age of 75. Smoking, alcoholism, obesity, anxiety disorders, diabetes and heart diseases are some of the important risk factors that can contribute towards ED in men.
If you accidentally overdose on this medication, seek immediate medical advice or call the Poison Helpline at 1-800-222-1222.
Since this drug is used on an as needed basis, there is no fixed dosing schedule. You can take the dose any time an hour prior to the intercourse.
1. Corbin, J. D., and S. H. Francis. "Pharmacology of phosphodiesterase-5 inhibitors." International journal of clinical practice 56.6 (2001): 453-459.
2. Huang, Sharon A., and Janette D. Lie. "Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction." Pharmacy and Therapeutics 38.7 (2013): 407.
3. DeBusk, Robert, et al. "Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel." The American journal of cardiology 86.2 (2000): 62-68.